Family Office Of America (FOFA) Operating Income Growth (3y) (2024 - 2026)

Family Office Of America (FOFA) Operating Income Growth (3y) (2024 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Op. Inc Growth (3y) (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	3.16%
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	19.80%
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	6.17%
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	31.84%
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	24.88%
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	35.44%
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	9.04%
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	60.19%
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	13.06%
10	Family Office Of America	27.84 Mn	27.20 Mn	532,674.00	54.49%

Download Data